Ochre Bio
Ochre Bio is a pioneering biotech company focused on rethinking liver therapy discovery and development. They leverage an unprecedented convergence of computational and multi-omic technologies to address the complexities of liver disease. Their mission is to develop RNA therapies for major liver health challenges, aiming to transform treatment options for patients worldwide. With a foundation built on decades of expertise in genomics, machine learning, drug discovery, and development, Ochre Bio is committed to addressing unmet needs in chronic liver disease globally.
Industries
Nr. of Employees
small (1-50)
Products
OB-220
A lead development candidate RNA therapy focused on treating significant liver fibrosis.
OB-220
A lead development candidate RNA therapy focused on treating significant liver fibrosis.
Services
Discovery service that generates and integrates human genomic and phenotypic data to identify and validate therapeutic targets using multi-omic analytics and human-system assays.
Design and chemistry services for RNA-based therapeutics, including progression from target to validated lead using human data-driven workflows.
Provision of curated human liver datasets and analytic support under data licence agreements to enable external research on disease drivers and therapeutic hypotheses.
Functional evaluation of candidates using diseased human liver tissue and whole-organ perfusion systems to support late-stage validation and translational assessment.
Discovery service that generates and integrates human genomic and phenotypic data to identify and validate therapeutic targets using multi-omic analytics and human-system assays.
Design and chemistry services for RNA-based therapeutics, including progression from target to validated lead using human data-driven workflows.
Provision of curated human liver datasets and analytic support under data licence agreements to enable external research on disease drivers and therapeutic hypotheses.
Functional evaluation of candidates using diseased human liver tissue and whole-organ perfusion systems to support late-stage validation and translational assessment.
Expertise Areas
- Liver disease therapeutics
- RNA therapeutics development
- Human-first translational research
- Computational biology and machine learning
Key Technologies
- RNA chemistry for therapeutics
- Multi-omics (genomics, transcriptomics)
- Computational biology and machine learning
- Spatial genomics / spatial biology